[Invasive cancer of the cervix. Treatment adapted as a function of the available therapeutic methods].
Forty-seven patients were treated for invasive cancer of the cervix from January 1978 till December 1985. Eleven patients were submitted to intracavitary radiation 6 weeks prior to surgery. The 5 years survival rate was 82%. The other 36 patients were treated by surgery alone because radiotherapy was impossible. The 5 years survival of the latter group was 71%: Stage I: 87.5%, Stage IIa: 60%, Stage IIb: 40%. The efficiency of the intracavitary radiation was remarkably evident in the stage II N (-), concerning central recurrences. An alternative to the classical treatment in advanced cancers using a preoperative chemotherapy is currently under investigation.
Abboud
J
J
Service de Gynécologie-Obstétrique, Hôtel-Dieu de France, Beyrouth, Liban.
Attieh
E
E
Germanos
A
A
D000230:Adenocarcinoma / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D000328:Adult; D001918:Brachytherapy / Q000592:standards*; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007044:Hysterectomy / Q000592:standards*; D007861:Lebanon / Q000453:epidemiology; D008197:Lymph Node Excision / Q000592:standards; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D016019:Survival Analysis; D015996:Survival Rate; D002583:Uterine Cervical Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*
Cancer invasif du col utérin. Traitement adapté en fonction des moyens thérapeutiques disponibles.